Shareholders approve 29th consecutive dividend increase to CHF 3.70 (+5.7%) per share for 2025, representing a 3.0% yield¹ Shareholders confirm Giovanni Caforio as Chair of the Board of Directors as ...
Novartis Pipeline Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines. Many of these projects, which include new molecular entities as well ...
Εξερευνήστε ευκαιρίες στη Novartis παρακάτω. (高级）医药代表 /（资深）产品专员 Regular (Sales), Full time Sales China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results